Medlea - Digital twins for predictive lung health

Medlea is an innovative company that develops digital twin solutions for lung diagnsosis and lung surgery. We offer a SaaS platform designed to enable clinicians, surgeons, pulmonologists, and healthcare professionals to perform detailed and accurate real-time preoperative simulations and morpho-functional analysis on private or public clouds. We enhance surgical planning, reduce operative risks, and optimize clinical outcomes.

Year of establishment:

2019

Number of employees:

FROM 3 TO 9 EMPLOYEES

Annual turnover:

Under 250.000 Euro

Reference year of turnover:

2022

Export turnover:

Less than 75.000 Euro

Activities:

Wholesale of computers, computer peripheral equipment and software

Other software publishing

Diagnostic imaging services and medical laboratory activities

No videos uploaded

No documents uploaded

Company:

MEDLEA S.R.L.

Address:

Via Angelo Poliziano 76

City:

Roma (RM)

Zip Code:

00184

No business proposals uploaded

Our main product, WeResp, employs a proprietary AI-based approach to accurately represent bronchiolar structure and lung functionality. This technology supports professionals in diagnosing and treating critical conditions such as nodules, emphysema, fibrosis, COVID-19 lesions, pleural effusions, and more. It is particularly useful in contexts such as lung surgeries, intensive care units for mechanical ventilation, and preventive screenings.
We collaborate with prestigious medical institutions like Policlinico Gemelli and the University Hospital of Alberta (Canada) to expand the application of our solutions to complex clinical scenarios, including post-transplant monitoring.